52 results
Page 2 of 3
DEFM14A
k3leqxjfqbz7
6 Nov 18
Proxy related to merger
12:00am
424B3
fm4crxy
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
8uxfh0e99n7ba7vndbw
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-2.1
sqoexla wt7z
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
ouqhieoil414 bn
9 Aug 18
Business combination disclosure
5:17pm
8-K
EX-1.1
o2o718
8 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
f6h10d jk
6 Mar 14
Entry into a Material Definitive Agreement
12:00am
424B3
y5f8mgkn
13 Sep 13
Prospectus supplement
12:00am
424B3
j56l2up7420tfsjc
13 Sep 13
Prospectus supplement
12:00am
424B3
qs2tyfy46fpi1knr67ph
13 Aug 13
Prospectus supplement
12:00am